Canada markets closed

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.08+0.70 (+3.61%)
At close: 04:00PM EDT
20.08 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
301,772
270,259
220,180
38,544
0
Cost of Revenue
49,467
33,407
22,895
9,100
0
Gross Profit
252,305
236,852
197,285
29,444
0
Operating Expenses
Research Development
87,259
76,097
65,490
99,297
112,042
Selling General and Administrative
139,064
129,427
97,951
85,948
45,321
Total Operating Expenses
282,847
262,048
187,512
186,080
157,363
Operating Income or Loss
-30,542
-25,196
9,773
-156,636
-157,363
Total Other Income/Expenses Net
8,978
8,544
1,253
97
-
Income Before Tax
-21,564
-16,652
11,026
-156,539
-156,229
Income Tax Expense
-30,214
-30,736
-172,337
1,385
5,152
Income from Continuing Operations
8,650
14,084
183,363
-157,924
-161,381
Net Income
8,650
14,084
183,363
-157,924
-161,381
Net Income available to common shareholders
8,650
14,084
183,363
-157,924
-161,381
Basic EPS
-0.10
-
2.64
-2.30
-2.61
Diluted EPS
-0.11
-
2.60
-2.30
-2.61
Basic Average Shares
69,868
-
69,382
68,577
61,843
Diluted Average Shares
70,172
-
70,421
68,577
61,843